Battle Creek, MI1 Active Studies

Substance Use Disorder Clinical Trials in Battle Creek, MI

Find 1 actively recruiting substance use disorder clinical trials in Battle Creek, MI. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
330
Enrolling

Recruiting Substance Use Disorder Studies in Battle Creek

About Substance Use Disorder Clinical Trials in Battle Creek

Substance use disorder is a condition where the use of substances leads to health issues, disability, and failure to meet responsibilities. It encompasses alcohol, opioid, stimulant, and other drug addictions. Treatment includes behavioral therapy, medication-assisted treatment, and support programs.

There are currently 1 substance use disorder clinical trials recruiting participants in Battle Creek, MI. These studies are seeking a combined 330 participants. Research is being sponsored by VA Office of Research and Development. Clinical trial participation is free and participants receive study-related medical care at no cost.

Substance Use Disorder Clinical Trials in Battle Creek — FAQ

Are there substance use disorder clinical trials in Battle Creek?

Yes, there are 1 substance use disorder clinical trials currently recruiting in Battle Creek, MI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Battle Creek?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Battle Creek research site will contact you about next steps.

Are clinical trials in Battle Creek free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Battle Creek studies also compensate for your time and travel.

What substance use disorder treatments are being tested?

The 1 active trials in Battle Creek are testing new therapies including novel drugs, biologics, and treatment approaches for substance use disorder.

Data updated July 13, 2026 from ClinicalTrials.gov